Valuation: Cipla Limited

Market Cap 1,17100Cr 1.23TCr 1.06TCr 997.67Cr 907.24Cr 1.7TCr 1.73TCr 12TCr 4.57TCr 59TCr 4.61TCr 4.51TCr 1,95700Cr P/E 2027 *
28.2x
P/E 2028 * 22.8x
Enterprise Value 1,06500Cr 1.12TCr 965.28Cr 907.32Cr 825.08Cr 1.55TCr 1.58TCr 11TCr 4.15TCr 53TCr 4.19TCr 4.1TCr 1,77900Cr EV / Sales 2027 *
3.44x
EV / Sales 2028 * 2.99x
Free-Float
68.87%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day-0.60%
1 week-0.94%
Current month-1.57%
1 month+0.83%
3 months+1.25%
6 months+8.90%
Current year-4.06%
1 week 1,449.2
Extreme 1449.2
1,483.7
1 month 1,366.1
Extreme 1366.1
1,491.2
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 24/07/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%-0.94%-7.29%+17.35% 1.23TCr
-0.10%-0.77%+17.58%+70.16% 4.84TCr
-3.26%-5.31%+52.47%+114.13% 3.97TCr
-2.75%+1.88%+14.81%+76.92% 1.18TCr
-0.58%-0.77%+29.90%+135.00% 906.17Cr
+1.56%+5.52%+23.69%+41.38% 756.57Cr
+0.52%+2.08%+42.23%-13.42% 717.59Cr
-0.07%+1.72%+13.39%+190.65% 684.21Cr
-2.51%-3.14%-30.53%+23.54% 576.86Cr
+1.61%+5.26%+36.74%+111.25% 479.87Cr
Average -0.62%+1.73%+19.30%+76.70% 1.53TCr
Weighted average by Cap. -1.12%+1.10%+25.20%+81.25%

Financials

2027 *2028 *
Net sales 31TCr 324.79Cr 280.79Cr 263.93Cr 240.01Cr 450.7Cr 458.48Cr 3.09TCr 1.21TCr 16TCr 1.22TCr 1.19TCr 52TCr 35TCr 364Cr 314.69Cr 295.79Cr 268.98Cr 505.11Cr 513.83Cr 3.47TCr 1.35TCr 17TCr 1.37TCr 1.34TCr 58TCr
Net income 4.14TCr 43Cr 37Cr 35Cr 32Cr 60Cr 61Cr 412.7Cr 161.23Cr 2.07TCr 162.64Cr 159.17Cr 6.91TCr 5.14TCr 54Cr 47Cr 44Cr 40Cr 75Cr 76Cr 513.19Cr 200.49Cr 2.58TCr 202.25Cr 197.93Cr 8.59TCr
Net Debt -11TCr -111.18Cr -96Cr -90Cr -82Cr -154.27Cr -156.94Cr -1.06TCr -413.59Cr -5.32TCr -417.22Cr -408.31Cr -18TCr -13TCr -137.77Cr -119.1Cr -111.95Cr -101.8Cr -191.17Cr -194.47Cr -1.31TCr -512.51Cr -6.59TCr -517.01Cr -505.97Cr -22TCr
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
14/26/14 ₹1,450.00 -0.60% 7,84,917
13/26/13 ₹1,458.80 -0.29% 4,40,742
12/26/12 ₹1,463.00 0.00% 6,21,021
11/26/11 ₹1,463.00 -0.32% 9,58,909
10/26/10 ₹1,467.70 +0.27% 6,62,981
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,450.00INR
Average target price
1,509.08INR
Spread / Average Target
+4.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock